{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T21:13:16Z","timestamp":1775682796449,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,8]]},"DOI":"10.7759\/cureus.106675","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T20:26:04Z","timestamp":1775679964000},"source":"Crossref","is-referenced-by-count":0,"title":["Immune-Mediated Demyelinating Polyradiculoneuropathies Linked to Systemic Lupus Erythematosus (SLE): A Systematic Review of Clinical Features, Diagnostic and Treatment Modalities"],"prefix":"10.7759","author":[{"given":"Abhishek","family":"Vadher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swati","family":"Baraiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Utsav","family":"Thakkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apoorv","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kesava Manikanta","family":"Achuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujata","family":"Kambhatla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Aringer M","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, et al.. 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019, 78:1151-9. 10.1136\/annrheumdis-2018-214819","journal-title":"Ann Rheum Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","article-title":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes","volume":"42","author":"The American College of Rheumatology","year":"1999","unstructured":"The American College of Rheumatology. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999, 42:4-599. 10.1002\/1529-0131(199904)42:4&lt;599::AID-ANR2&gt;3.0.CO;2-F","journal-title":"Arthritis Rheum"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.05.002","article-title":"Autoimmune diseases and their relation with immunological, neurological and endocrinological axes","volume":"16","author":"Coronel-Restrepo N","year":"2017","unstructured":"Coronel-Restrepo N, Posso-Osorio I, Naranjo-Escobar J, Tob\u00f3n GJ. Autoimmune diseases and their relation with immunological, neurological and endocrinological axes. Autoimmun Rev. 2017, 16:684-92. 10.1016\/j.autrev.2017.05.002","journal-title":"Autoimmun Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison HJ","year":"2016","unstructured":"Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barr\u00e9 syndrome. Lancet. 2016, 388:717-727. 10.1016\/S0140-6736(16)00339-1","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14959","article-title":"European Academy of Neurology\/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force-second revision","volume":"28","author":"Van den Bergh PY","year":"2021","unstructured":"Van den Bergh PY, van Doorn PA, Hadden RD, et al.. European Academy of Neurology\/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force-second revision. Eur J Neurol. 2021, 28:3556-83. 10.1111\/ene.14959","journal-title":"Eur J Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-023-10075-w","article-title":"Cyclophosphamide in the treatment of systemic lupus erythematosus-related Guillain-Barr\u00e9 syndrome: a systematic review of case reports","volume":"18","author":"Xiong A","year":"2023","unstructured":"Xiong A, Cui H, Deng R, Wei X. Cyclophosphamide in the treatment of systemic lupus erythematosus-related Guillain-Barr\u00e9 syndrome: a systematic review of case reports. J Neuroimmune Pharmacol. 2023, 18:285-93. 10.1007\/s11481-023-10075-w","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2024-001244","article-title":"Clinical features of Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyradiculoneuritis associated with SLE","volume":"11","author":"Wang J","year":"2024","unstructured":"Wang J, Zhang Z, Qian J, et al.. Clinical features of Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyradiculoneuritis associated with SLE. Lupus Sci Med. 2024, 11:10.1136\/lupus-2024-001244","journal-title":"Lupus Sci Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2005.08.008","article-title":"Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome","volume":"35","author":"Vina ER","year":"2005","unstructured":"Vina ER, Fang AJ, Wallace DJ, Weisman MH. Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome. Semin Arthritis Rheum. 2005, 35:175-84. 10.1016\/j.semarthrit.2005.08.008","journal-title":"Semin Arthritis Rheum"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.09.018","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy associated with systemic lupus erythematosus","volume":"51","author":"Julio PR","year":"2021","unstructured":"Julio PR, Cort\u00eas MM, Costallat LT, Gaino JZ, Fran\u00e7a MC Jr, Appenzeller S. Chronic inflammatory demyelinating polyradiculoneuropathy associated with systemic lupus erythematosus. Semin Arthritis Rheum. 2021, 51:158-65. 10.1016\/j.semarthrit.2020.09.018","journal-title":"Semin Arthritis Rheum"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(06)70603-2","article-title":"Clinical and electrophysiological predictors of respiratory failure in Guillain-Barr\u00e9 syndrome: a prospective study","volume":"5","author":"Durand MC","year":"2006","unstructured":"Durand MC, Porcher R, Orlikowski D, et al.. Clinical and electrophysiological predictors of respiratory failure in Guillain-Barr\u00e9 syndrome: a prospective study. Lancet Neurol. 2006, 5:1021-8. 10.1016\/S1474-4422(06)70603-2","journal-title":"Lancet Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1385\/NCC:1:4:415","article-title":"Respiratory dysfunction in Guillain-Barr\u00e9 Syndrome","volume":"1","author":"Orlikowski D","year":"2004","unstructured":"Orlikowski D, Prigent H, Sharshar T, Lofaso F, Raphael JC. Respiratory dysfunction in Guillain-Barr\u00e9 Syndrome. Neurocrit Care. 2004, 1:415-22. 10.1385\/NCC:1:4:415","journal-title":"Neurocrit Care"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6","article-title":"Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barr\u00e9 syndrome","volume":"824945","author":"Ho TW","year":"1999","unstructured":"Ho TW, Willison HJ, Nachamkin I, et al.. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barr\u00e9 syndrome. Ann Neurol. 1999, 824945:2-168. 10.1002\/1531-8249(199902)45:2&lt;168::AID-ANA6&gt;3.0.CO;2-6","journal-title":"Ann Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-002-0653-2","article-title":"Peripheral neuropathy in systemic lupus erythematosus: pathomorphological features and distribution pattern of matrix metalloproteinases","volume":"105","author":"Mawrin C","year":"2003","unstructured":"Mawrin C, Brunn A, R\u00f6cken C, Schr\u00f6der JM. Peripheral neuropathy in systemic lupus erythematosus: pathomorphological features and distribution pattern of matrix metalloproteinases. Acta Neuropathol. 2003, 105:365-72. 10.1007\/s00401-002-0653-2","journal-title":"Acta Neuropathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30144-9","article-title":"Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy","volume":"18","author":"Bunschoten C","year":"2019","unstructured":"Bunschoten C, Jacobs BC, Van den Bergh PYK, Cornblath DR, van Doorn PA. Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy. Lancet Neurol. 2019, 18:784-794. 10.1016\/S1474-4422(19)30144-9","journal-title":"Lancet Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.0781","article-title":"Monitoring clinical course and treatment response in chronic inflammatory demyelinating polyneuropathy during routine care: a review of clinical and laboratory assessment measures","volume":"77","author":"Allen JA","year":"2020","unstructured":"Allen JA, Merkies IS, Lewis RA. Monitoring clinical course and treatment response in chronic inflammatory demyelinating polyneuropathy during routine care: a review of clinical and laboratory assessment measures. JAMA Neurol. 2020, 77:1159-66. 10.1001\/jamaneurol.2020.0781","journal-title":"JAMA Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.5152\/npa.2017.18091","article-title":"Guillain-Barr\u00e9 syndrome and its variants: clinical course and prognostic factors","volume":"56","author":"B\u00f6l\u00fckba\u015fi F","year":"2019","unstructured":"B\u00f6l\u00fckba\u015fi F, Ersen G, G\u00fcnd\u00fcz A, et al.. Guillain-Barr\u00e9 syndrome and its variants: clinical course and prognostic factors. Noro Psikiyatr Ars. 2019, 56:71-4. 10.5152\/npa.2017.18091","journal-title":"Noro Psikiyatr Ars"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/cc10312","article-title":"Give or take? Intravenous immunoglobulin or plasma exchange for Guillain-Barr\u00e9 syndrome","volume":"15","author":"Hughes RA","year":"2011","unstructured":"Hughes RA. Give or take? Intravenous immunoglobulin or plasma exchange for Guillain-Barr\u00e9 syndrome. Crit Care. 2011, 15:174. 10.1186\/cc10312","journal-title":"Crit Care"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1177\/09612033231186718","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with systemic lupus erythematosus without systemic activity","volume":"32","author":"Calixto OJ","year":"2023","unstructured":"Calixto OJ, Poveda S, Meneses-Toro MA, Vera-Parra EC, Romero-S\u00e1nchez C, Guzman Molano LF, Bello-Gualtero JM. Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with systemic lupus erythematosus without systemic activity. Lupus. 2023, 32:1123-5. 10.1177\/09612033231186718","journal-title":"Lupus"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1177\/0961203320948181","article-title":"Immunosuppressive therapy of systemic lupus erythematosus associated peripheral neuropathy: a systematic review","volume":"29","author":"Constantin A","year":"2020","unstructured":"Constantin A, N\u0103stase D, Tulb\u0103 D, B\u0103l\u0103nescu P, B\u0103icu\u0219 C. Immunosuppressive therapy of systemic lupus erythematosus associated peripheral neuropathy: a systematic review. Lupus. 2020, 29:1509-19. 10.1177\/0961203320948181","journal-title":"Lupus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/470015-immune-mediated-demyelinating-polyradiculoneuropathies-linked-to-systemic-lupus-erythematosus-sle-a-systematic-review-of-clinical-features-diagnostic-and-treatment-modalities","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T20:26:04Z","timestamp":1775679964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/470015-immune-mediated-demyelinating-polyradiculoneuropathies-linked-to-systemic-lupus-erythematosus-sle-a-systematic-review-of-clinical-features-diagnostic-and-treatment-modalities"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.106675","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,8]]}}}